IRIDEX CORP Files Definitive Proxy Statement for 2025 Annual Meeting
Ticker: IRIX · Form: DEF 14A · Filed: Apr 28, 2025 · CIK: 1006045
| Field | Detail |
|---|---|
| Company | Iridex Corp (IRIX) |
| Form Type | DEF 14A |
| Filed Date | Apr 28, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, corporate-governance
TL;DR
IRIDEX proxy filed - vote on directors & auditors for June 11 meeting.
AI Summary
IRIDEX CORP filed its definitive proxy statement on April 28, 2025, for its annual meeting on June 11, 2025. The filing details executive compensation, board nominations, and other corporate governance matters. The company is seeking shareholder approval for routine business, including the election of directors and ratification of its independent registered public accounting firm.
Why It Matters
This filing provides shareholders with crucial information to make informed decisions regarding the company's leadership and strategic direction, impacting their investment.
Risk Assessment
Risk Level: low — This is a routine proxy filing for an annual meeting, not indicating immediate financial distress or significant new risks.
Key Players & Entities
- IRIDEX CORP (company) — Registrant
- 0001174947-25-000633.txt (document) — Filing document name
- 20250428 (date) — Filing date
- 20250611 (date) — Meeting date
FAQ
What is the purpose of this DEF 14A filing?
The purpose of this DEF 14A filing is to provide shareholders with a proxy statement for the IRIDEX CORP annual meeting scheduled for June 11, 2025, detailing matters to be voted upon.
When was the definitive proxy statement filed?
The definitive proxy statement was filed on April 28, 2025.
What is the company's fiscal year end?
IRIDEX CORP's fiscal year ends on December 28.
Where is IRIDEX CORP headquartered?
IRIDEX CORP's business address is 1212 Terra Bella Ave, Mountain View, CA 94043.
What is the SIC code for IRIDEX CORP?
The Standard Industrial Classification (SIC) code for IRIDEX CORP is 3845, which corresponds to ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 28, 2025 regarding IRIDEX CORP (IRIX).